Cite
HARVARD Citation
Kubo, T. et al. (2021). Epithelioid granulomatous lesions express abundant programmed death ligand-1 (PD-L1): a discussion of adverse events in anti-PD-1 antibody-based cancer immunotherapy. Human vaccines & immunotherapeutics. 17 (7), pp. 1940-1942. [Online].